In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. Academic Article uri icon

Overview

MeSH Major

  • Myocardial Infarction
  • Neovascularization, Physiologic
  • Transcription Factors
  • Vascular Endothelial Growth Factor A
  • Ventricular Function

abstract

  • VEGF administration to infarcted myocardium enhances the efficacy of GMT-mediated cellular reprogramming in improving myocardial function and reducing the extent of myocardial fibrosis compared with the use of GMT or VEGF alone.

publication date

  • December 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3540681

Digital Object Identifier (DOI)

  • 10.1161/JAHA.112.005652

PubMed ID

  • 23316332

Additional Document Info

start page

  • e005652

volume

  • 1

number

  • 6